Primary Immunodeficiencies (PID)

Immunology·MeSH: Immunologic Deficiency Syndromes

Prevalence

5.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Primary Immunodeficiencies (PID)?

There are 1 clinical trial targeting Primary Immunodeficiencies (PID) tracked by BioSniper.

What is the prevalence of Primary Immunodeficiencies (PID)?

The estimated prevalence of Primary Immunodeficiencies (PID) is approximately 5.0 per 100,000 population.

Deep-dive into Primary Immunodeficiencies (PID)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Primary Immunodeficiencies (PID) — Drugs in Development & Clinical Trials | BioSniper